Board Meeting21 Oct 2026, 01:03 pm
Genomic Valley Biotech Board Meeting on Oct 30, 2026
AI Summary
Genomic Valley Biotech Ltd has announced that its Board of Directors will convene on October 30, 2026, to approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The trading window for dealing in the company's securities will be closed from October 1, 2026, until 48 hours after the results are publicly announced, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key Highlights
- Board meeting scheduled for October 30, 2026.
- Unaudited financial results for Q2 FY27 to be approved.
- Trading window closed from October 1, 2026, to October 30, 2026.
- Insider trading regulations are in effect during the closure.
Price Impact
More from GVBL